Crewe Advisors LLC acquired a new position in The Clorox Company (NYSE:CLX – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 355 shares of the company’s stock, valued at approximately $56,000.
Several other institutional investors have also added to or reduced their stakes in the company. Kennon Green & Company LLC grew its stake in Clorox by 4.4% in the 1st quarter. Kennon Green & Company LLC now owns 1,558 shares of the company’s stock worth $247,000 after acquiring an additional 66 shares in the last quarter. GHP Investment Advisors Inc. grew its position in shares of Clorox by 1.3% during the 4th quarter. GHP Investment Advisors Inc. now owns 5,132 shares of the company’s stock worth $720,000 after buying an additional 66 shares in the last quarter. M Holdings Securities Inc. grew its holdings in Clorox by 0.9% during the 4th quarter. M Holdings Securities Inc. now owns 7,523 shares of the company’s stock worth $1,056,000 after acquiring an additional 68 shares in the last quarter. Bontempo Ohly Capital Mgmt LLC increased its position in Clorox by 0.3% during the 4th quarter. Bontempo Ohly Capital Mgmt LLC now owns 22,120 shares of the company’s stock valued at $3,104,000 after purchasing an additional 72 shares during the period. Finally, Parkside Financial Bank & Trust lifted its position in shares of Clorox by 16.8% in the 1st quarter. Parkside Financial Bank & Trust now owns 500 shares of the company’s stock worth $79,000 after purchasing an additional 72 shares during the period. Institutional investors own 77.98% of the company’s stock.
Clorox Stock Performance
Clorox stock traded up $0.26 during mid-day trading on Wednesday, hitting $153.72. The company had a trading volume of 143,332 shares, compared to its average volume of 1,198,128. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 6.38. The company has a market capitalization of $19.04 billion, a price-to-earnings ratio of 128.98, a P/E/G ratio of 2.25 and a beta of 0.28. The company’s fifty day moving average is $156.32 and its 200-day moving average is $158.10. The Clorox Company has a 12-month low of $124.58 and a 12-month high of $178.21.
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings results on Wednesday, August 2nd. The company reported $1.67 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.19 by $0.48. The company had revenue of $2.02 billion for the quarter, compared to the consensus estimate of $1.88 billion. Clorox had a return on equity of 163.56% and a net margin of 2.02%. Clorox’s revenue for the quarter was up 12.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.93 earnings per share. Equities research analysts predict that The Clorox Company will post 5.87 EPS for the current year.
Clorox Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, August 25th. Investors of record on Wednesday, August 9th were given a dividend of $1.20 per share. This represents a $4.80 annualized dividend and a dividend yield of 3.12%. The ex-dividend date of this dividend was Tuesday, August 8th. This is an increase from Clorox’s previous quarterly dividend of $1.18. Clorox’s dividend payout ratio is 403.36%.
Analysts Set New Price Targets
A number of equities analysts recently commented on CLX shares. Barclays boosted their price objective on shares of Clorox from $117.00 to $127.00 and gave the stock an “underweight” rating in a research note on Friday, August 4th. DA Davidson increased their price target on shares of Clorox from $155.00 to $176.00 and gave the company a “neutral” rating in a research report on Monday, August 7th. Atlantic Securities upgraded shares of Clorox from an “underweight” rating to a “neutral” rating in a research note on Thursday, August 3rd. Finally, StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a report on Thursday, August 31st. Seven equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $150.38.
View Our Latest Stock Analysis on Clorox
Insider Activity at Clorox
In other Clorox news, CFO Kevin B. Jacobsen sold 3,346 shares of Clorox stock in a transaction on Monday, August 14th. The shares were sold at an average price of $160.82, for a total transaction of $538,103.72. Following the sale, the chief financial officer now owns 23,224 shares of the company’s stock, valued at approximately $3,734,883.68. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.41% of the stock is currently owned by corporate insiders.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Clorox and related companies with MarketBeat.com’s FREE daily email newsletter.
Leave a Reply